What is he best known for?
The fields of study he is best known for:
Biotechnology, Genetically modified crops, Good manufacturing practice, Transgene and Genetics are his primary areas of study.
In general Biotechnology study, his work on Biosafety often relates to the realm of Human use, thereby connecting several areas of interest.
His Genetically modified crops study incorporates themes from Human proteins, Biopharmaceutical and Genetically modified organism.
His work in Genetically modified organism addresses issues such as Bacillus thuringiensis, which are connected to fields such as Botany.
As a part of the same scientific study, Richard M. Twyman usually deals with the Good manufacturing practice, concentrating on Recombinant DNA and frequently concerns with Plant cell.
His study looks at the relationship between Transgene and topics such as Transformation, which overlap with Phenotype, Gene expression, Promoter and Regulation of gene expression.
His most cited work include:
- Molecular farming in plants: host systems and expression technology. (536 citations)
- Plant-based production of biopharmaceuticals. (534 citations)
- Plant cell cultures for the production of recombinant proteins (454 citations)
What are the main themes of his work throughout his whole career to date?
Richard M. Twyman mostly deals with Biotechnology, Genetics, Transgene, Genetically modified crops and Gene.
His studies deal with areas such as Developing country, Recombinant DNA and Good manufacturing practice as well as Biotechnology.
His study in Developing country is interdisciplinary in nature, drawing from both Food security and Subsistence agriculture.
His study ties his expertise on Transformation together with the subject of Transgene.
His Genetically modified crops study frequently draws connections to adjacent fields such as Monoclonal antibody.
As part of his studies on Gene, Richard M. Twyman often connects relevant subjects like Botany.
He most often published in these fields:
- Biotechnology (28.73%)
- Genetics (15.47%)
- Transgene (11.60%)
What were the highlights of his more recent work (between 2014-2020)?
- Biotechnology (28.73%)
- Biochemistry (10.50%)
- Monoclonal antibody (3.31%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Biotechnology, Biochemistry, Monoclonal antibody, Genetics and Biochemical engineering.
The study incorporates disciplines such as Carotenoid and Genetically modified organism in addition to Biotechnology.
His Endoplasmic reticulum, Biosynthesis, Recombinant DNA and Organelle study in the realm of Biochemistry interacts with subjects such as Lipid Droplet Proteins.
The concepts of his Biosynthesis study are interwoven with issues in Biogenesis, Botany, Receptor, Fucose and Glycan.
His Recombinant DNA research incorporates elements of Protein biosynthesis, Plant cell, Protein activity and Tissue culture.
His studies in Monoclonal antibody integrate themes in fields like Genetically modified crops, Molecular biology, Downstream processing and Chinese hamster ovary cell.
Between 2014 and 2020, his most popular works were:
- Regulatory approval and a first‐in‐human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants (118 citations)
- The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter Nanorods (100 citations)
- Insect antimicrobial peptides show potentiating functional interactions against Gram-negative bacteria. (92 citations)
In his most recent research, the most cited papers focused on:
Richard M. Twyman mainly investigates Biotechnology, Genetics, Biochemistry, CRISPR and Genome.
He works in the field of Biotechnology, focusing on Biopharmaceutical in particular.
Richard M. Twyman regularly ties together related areas like Disease in his Genetics studies.
His Biochemistry research incorporates themes from Botany and Polymer.
His CRISPR research integrates issues from Nuclease and Meganuclease.
His study in the fields of Genome engineering and CRISPR interference under the domain of Genome overlaps with other disciplines such as Streptococcus pyogenes.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
